Cargando…
Emerging treatment options for BRAF-mutant colorectal cancer
The personalization of cancer care is rooted in the premise that there are subsets of patients with tumors harboring clinically relevant targets for patient-specific treatments. Colorectal cancer (CRC) is a disease that has historically been notable for its dearth of biomarkers that are predictive o...
Autores principales: | Ursem, Carling, Atreya, Chloe E, Van Loon, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889076/ https://www.ncbi.nlm.nih.gov/pubmed/29628780 http://dx.doi.org/10.2147/GICTT.S125940 |
Ejemplares similares
-
Targeting mutant BRAF in colorectal cancer
por: Carroll, David, et al.
Publicado: (2013) -
Exploring the best treatment options for BRAF-mutant metastatic colon cancer
por: Taieb, Julien, et al.
Publicado: (2019) -
Comment on: “Exploring the best treatment options for BRAF-mutant metastatic colon cancer”
por: Milano, Gérard, et al.
Publicado: (2020) -
Combination drug development in BRAF mutant colorectal cancer
por: Lam, Michael, et al.
Publicado: (2018) -
Molecular targeted therapy of BRAF-mutant colorectal cancer
por: Ducreux, Michel, et al.
Publicado: (2019)